Engrailed-2 might play an anti-oncogenic role in clear-cell renal cell carcinoma

被引:0
|
作者
Cai-yong Lai
Yin Xu
Gan-shen Yu
Xun Wu
Yun-fei Li
Bin Pan
Bao-li Heng
Yi-jun Xue
Ze-xuan Su
机构
[1] The First Affiliated Hospital of Jinan University,Department of Urology
[2] The First Affiliated Hospital of Gannan Medical College,Department of Urology
来源
Journal of Molecular Histology | 2016年 / 47卷
关键词
Engrailed-2; Clear-cell renal cell carcinoma; Anti-oncogene;
D O I
暂无
中图分类号
学科分类号
摘要
Our preliminary study indicated that Engrailed-2 (EN2) is downregulated but also ectopically expressed in clear-cell renal cell carcinoma (CCRCC), and the absence of EN2 expression was associated with poor histological grade. However, the specific roles of EN2 in CCRCC have yet to be elucidated. In the present study, we examined the effects of inhibiting EN2 expression by human renal tubular epithelial cells (HK-2) and overexpressing EN2 by human clear-cell renal cells (786-O). Results showed that EN2 inhibition accelerated HK-2 cell proliferation, shortened the cell cycle, reduced apoptosis, and acted more invasively. By contrast, EN2 overexpression in 786-O cells decelerated the proliferative ability of 786-O, increased the percentage of cell apoptosis, and weakened the invasive ability. Overall, the results demonstrated that EN2 might play an anti-oncogenic role in oncogenesis and development of CCRCC, thereby maintaining the normal growth of human renal tubular epithelial cells.
引用
收藏
页码:229 / 237
页数:8
相关论文
共 50 条
  • [21] Re: Sorafenib in advanced clear-cell renal cell carcinoma
    Karakiewicz, Pierre I.
    Hutterer, Georg
    EUROPEAN UROLOGY, 2007, 52 (01) : 279 - 280
  • [22] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [23] Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
    Vuong, Lynda
    Kotecha, Ritesh R.
    Voss, Martin H.
    Hakimi, A. Ari
    CANCER DISCOVERY, 2019, 9 (10) : 1349 - 1357
  • [24] The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy
    Clark, Peter E.
    KIDNEY INTERNATIONAL, 2009, 76 (09) : 939 - 945
  • [25] Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)
    Drabkin, Harry A.
    Gemmill, Robert M.
    ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 : 39 - 56
  • [26] Integrated molecular analysis of clear-cell renal cell carcinoma
    Sato, Yusuke
    Yoshizato, Tetsuichi
    Shiraishi, Yuichi
    Maekawa, Shigekatsu
    Okuno, Yusuke
    Kamura, Takumi
    Shimamura, Teppei
    Sato-Otsubo, Aiko
    Nagae, Genta
    Suzuki, Hiromichi
    Nagata, Yasunobu
    Yoshida, Kenichi
    Kon, Ayana
    Suzuki, Yutaka
    Chiba, Kenichi
    Tanaka, Hiroko
    Niida, Atsushi
    Fujimoto, Akihiro
    Tsunoda, Tatsuhiko
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Sugano, Sumio
    Fukayama, Masashi
    Aburatani, Hiroyuki
    Sanada, Masashi
    Miyano, Satoru
    Homma, Yukio
    Ogawa, Seishi
    NATURE GENETICS, 2013, 45 (08) : 860 - U191
  • [27] Dystroglycan expression in clear-cell type renal cell carcinoma
    Camerini, A.
    De Luca, F.
    Genovese, G.
    De Paola, B.
    Valsuani, C.
    Tartarelli, G.
    Donati, S.
    Rettino, A.
    Cittadini, A.
    Sgambato, A.
    Gentili, C.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI34 - XI35
  • [28] Sorafenib in advanced clear-cell renal-cell carcinoma
    Escudier, Bernard
    Eisen, Tim
    Stadler, Walter M.
    Szczylik, Cezary
    Oudard, Stephane
    Siebels, Michael
    Negrier, Sylvie
    Chevreau, Christine
    Solska, Ewa
    Desai, Apurva A.
    Rolland, Frederic
    Demkow, Tomasz
    Hutson, Thomas E.
    Gore, Martin
    Freeman, Scott
    Schwartz, Brian
    Shan, Minghua
    Simantov, Ronit
    Bukowski, Ronald M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 125 - 134
  • [29] The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
    Fujiang Xu
    Kun Chang
    Jian Ma
    Yuanyuan Qu
    Huyang Xie
    Bo Dai
    Hualei Gan
    Hailiang Zhang
    Guohai Shi
    Yao Zhu
    Yiping Zhu
    Yijun Shen
    Dingwei Ye
    Scientific Reports, 7
  • [30] The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
    Xu, Fujiang
    Chang, Kun
    Ma, Jian
    Qu, Yuanyuan
    Xie, Huyang
    Dai, Bo
    Gan, Hualei
    Zhang, Hailiang
    Shi, Guohai
    Zhu, Yao
    Zhu, Yiping
    Shen, Yijun
    Ye, Dingwei
    SCIENTIFIC REPORTS, 2017, 7